Home » Topics » Regulatory

Regulatory
RSS

SmithKline Beecham submits sNDA for Paxil for use in PTSD

July 25, 2000

Fibrate/statin combinations claimed in recent patent literature by Bayer

July 24, 2000

Neuroprotective effects described for SB-269970

July 24, 2000

U.K. launch announced for Zyban

July 24, 2000

First regulatory approval obtained for Migard

July 21, 2000

Zambon and Sheffield submit IND for MSI-cromolyn

July 21, 2000

DepoMed's Metformin GR gives positive multiple-dose phase I results

July 21, 2000

NeisVac-C meningococcal vaccine approved in U.K.

July 21, 2000

Alcon to develop drop formulation of moxifloxacin

July 21, 2000

New label change granted for Wyeth-Ayerst's Effexor XR

July 19, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...